Moderna (NASDAQ:MRNA) was in focus Thursday morning after the vaccine maker announced plans to expand its cost efficiency and prioritization programs amid declining sales of its Covid shots. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback